SGLT2 INHIBITION IN HEART FAILURE WITH A REDUCED EJECTION FRACTION: HOW MANY PATIENTS WOULD BENEFIT?

被引：1
|
作者：
Hooper, Jacquelyn [1 ]
Shaw, Steven [1 ]
Callan, Paul [1 ]
Williams, Simon [1 ]
机构：
[1] Wythenshawe Hosp, Manchester, Lancs, England
来源：
HEART | 2021年 / 107卷
关键词：
D O I：
10.1136/heartjnl-2021-BCS.147
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
150
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [1] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Uday Sankar Das
    Aritra Paul
    Suvro Banerjee
    The Egyptian Heart Journal, 73
  • [2] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Das, Uday Sankar
    Paul, Aritra
    Banerjee, Suvro
    EGYPTIAN HEART JOURNAL, 2021, 73 (01):
  • [3] SGLT2 inhibition in heart failure with reduced or preserved ejection fraction: Finding the right patients to treat
    Girerd, Nicolas
    Zannad, Faiez
    JOURNAL OF INTERNAL MEDICINE, 2023, 293 (05) : 550 - 558
  • [4] SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction
    Nuzzi, Vincenzo
    Manca, Paolo
    Parisi, Francesca
    Madaudo, Cristina
    Sciacca, Sergio
    Cannizzo, Noemi
    Mule, Massimiliano
    Cipriani, Manlio G.
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (11)
  • [5] SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?
    Raschi, Emanuel
    Fadini, Gian Paolo
    Diemberger, Igor
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (05) : 647 - 650
  • [6] Cardiac remodeling with SGLT2 inhibitors in heart failure with reduced ejection fraction
    Romeo, Francisco J.
    Del Buono, Marco G.
    Aguilar-gallardo, Jose S.
    Lorente-ros, Marta
    Damonte, Juan I.
    Chiabrando, Juan G.
    Dixon, Dave L.
    Biondi-zoccai, Giuseppe
    Abbate, Antonio
    Carbone, Salvatore
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (01) : 95 - 97
  • [7] Monitoring SGLT2 inhibition effectiveness on pulmonary systolic pressure in heart failure with reduced ejection fraction
    Stracqualursi, Marco
    Nemola, Giulia
    Santangelo, Gloria
    Moscardelli, Silvia
    Bursi, Francesca
    Guazzi, Marco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 428
  • [8] The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction
    Genuardi, Michael, V
    Mather, Paul J.
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2021, 15
  • [9] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    Lisenby, Katelin M.
    Osmonson, Alyssa
    PHARMACOTHERAPY, 2021, 41 (06): : 526 - 536
  • [10] SGLT2 Inhibition in Heart Failure with Preserved Ejection Fraction - The New Frontier
    Aguiar-Neves, Ines
    Santos-Ferreira, Diogo
    Fontes-Carvalho, Ricardo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (01)
12345